Patents by Inventor Da Fu

Da Fu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12116422
    Abstract: The present disclosure provides a stapled peptide and use thereof in preparation of a drug for treating pancreatic cancer, belonging to the technical field of biomedicine. The stapled peptide is prepared by using a linear peptide with an amino acid sequence shown in SEQ ID NO: 1 as a peptide chain template, and replacing i-th and (i+7)-th amino acids of the linear peptide with S5 separately and conducting cyclization; alternatively, replacing n-th and (n+4)-th amino acids of the linear peptide with S5 separately and conducting cyclization; where S5 is 2-amino-2-methyl-6-heptenoic acid; i is a positive integer of less than or equal to 7, and n is a positive integer of less than or equal to 10. The stapled peptide treats LINC00261-deficient pancreatic cancer, N1DARP-deficient pancreatic cancer, or gemcitabine-resistant pancreatic cancer by specifically inhibiting a deubiquitination activity of USP10.
    Type: Grant
    Filed: December 12, 2022
    Date of Patent: October 15, 2024
    Assignee: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
    Inventors: Baiyong Shen, Shuyu Zhai, Da Fu, Xiaxing Deng, Xiaomei Tang
  • Publication number: 20230416305
    Abstract: The present disclosure provides a stapled peptide and use thereof in preparation of a drug for treating pancreatic cancer, belonging to the technical field of biomedicine. The stapled peptide is prepared by using a linear peptide with an amino acid sequence shown in SEQ ID NO: 1 as a peptide chain template, and replacing i-th and (i+7)-th amino acids of the linear peptide with S5 separately and conducting cyclization; alternatively, replacing n-th and (n+4)-th amino acids of the linear peptide with S5 separately and conducting cyclization; where S5 is 2-amino-2-methyl-6-heptenoic acid; i is a positive integer of less than or equal to 7, and n is a positive integer of less than or equal to 10. The stapled peptide treats LINC00261-deficient pancreatic cancer, N1DARP-deficient pancreatic cancer, or gemcitabine-resistant pancreatic cancer by specifically inhibiting a deubiquitination activity of USP10.
    Type: Application
    Filed: December 12, 2022
    Publication date: December 28, 2023
    Inventors: Baiyong SHEN, Shuyu ZHAI, Da FU, Xiaxing DENG, Xiaomei TANG
  • Publication number: 20150207917
    Abstract: The present invention provides a mobile terminal anti-theft method (100) which comprises triggering mobile terminal anti-theft operations according to operations on a mobile terminal (S110). The mobile terminal anti-theft operations at least comprise: collecting location information and environment information of the mobile terminal (S122, S124) and backing up private data of the mobile terminal (S126) and sending the collected location information and environment information and the backup private data to a result designated location (S130). The present disclosure further provides a mobile terminal (200) for achieving the mobile terminal anti-theft method (100).
    Type: Application
    Filed: March 7, 2013
    Publication date: July 23, 2015
    Inventors: Xiao Yang, Da Fu, Zhaoxin Gai, Linlin Gong, Guangyan Liu, Xia Zou
  • Publication number: 20130281077
    Abstract: A service management platform provides a manager device the ability to provision, manage, and monitor managed devices through a manager device interface to the service management platform. The service management platform allows for a manager device to configure and modify various profiles by determining one or more governing policies to be associated with respective profiles. The service management platform allows for the manager device to provision managed devices by the service management platform applying selected profiles to respective selected devices. The service management platform further allows for the manager device to monitor one or more managed devices by providing managed device usage data to the manager device, based on requests originating at the manager device.
    Type: Application
    Filed: March 15, 2013
    Publication date: October 24, 2013
    Inventors: Shihong Zou, Yu Lin, Wenyong Shi, Ian Andersen, Christopher Conrad Edwards, Da Fu, Jian Hong Ou, Renjith Ramachandran, Victoria Repice